Company: SHPH
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001493152-25-002253
Chunk: 195

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-15
Form: S-1
Chunk 195
---
               |  2,697,849 |   |
| Common stock issued for restricted                                                                              
 stock units                                                                                                     |     |                   |      — |   |     |        | — |     |        |    10,650 |     |        |  — |     |         |          — |   |     |        |       — |   |     |             | —           |   |     |               |          — |   |
| Stock-based compensation                                                                                        |     |                   |      — |   |     |        | — |     |        |         — |     |        |  — |     |         |    181,960 |   |     |        |       — |   |     |             | —           |   |     |               |    181,960 |   |
| Net loss                                                                                                        |     |                   |      — |   |     |        | — |     |        |         — |     |        |  — |     |         |          — |   |     |        |       — |   |     |             | (6,592,723  | ) |     |               | (6,592,723 | ) |
| Balance at December 31, 2023                                                                                    
 (as restated)                                                                                                   |     |                   |      — |   |     | $      | — |     |        | 2,008,689 |     | $      | 20 |     | $       | 29,489,055 |   |     | $      |       — |   |     | $           | (25,433,304 | ) |     | $             |  4,055,771 |   |
| Balance                                                                                                         |     |                   |      — |   |     | $      | — |     |        | 2,008,689 |     | $      | 20 |     | $       | 29,489,055 |   |     | $      |       — |   |     | $           | (25,433,304 | ) |     | $             |  4,055,771 |   |

<div align='center'>The accompanying notes are an integral part of these consolidated financial statements.</div>

| F-24 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Consolidated Statements of Cash Flows</div>

| CASH FLOWS FROM OPERATING ACTIVITIES: